These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23836187)

  • 1. Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment.
    Sionov E; Chang YC; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5127-30. PubMed ID: 23836187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
    Sionov E; Chang YC; Garraffo HM; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2804-15. PubMed ID: 19414582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress.
    Chang YC; Khanal Lamichhane A; Kwon-Chung KJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans.
    Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
    PLoS One; 2012; 7(3):e33022. PubMed ID: 22412978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.
    Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
    FEMS Yeast Res; 2012 Nov; 12(7):748-54. PubMed ID: 22731401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
    Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.
    Sionov E; Lee H; Chang YC; Kwon-Chung KJ
    PLoS Pathog; 2010 Apr; 6(4):e1000848. PubMed ID: 20368972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heteroresistance of Cryptococcus gattii to fluconazole.
    Varma A; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2303-11. PubMed ID: 20385871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
    Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C
    mBio; 2016 May; 7(3):. PubMed ID: 27165800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
    Sionov E; Chang YC; Garraffo HM; Dolan MA; Ghannoum MA; Kwon-Chung KJ
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1162-9. PubMed ID: 22155829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans.
    Yamazumi T; Pfaller MA; Messer SA; Houston AK; Boyken L; Hollis RJ; Furuta I; Jones RN
    J Clin Microbiol; 2003 Jan; 41(1):267-72. PubMed ID: 12517859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
    Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
    Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.
    Sanguinetti M; Posteraro B; La Sorda M; Torelli R; Fiori B; Santangelo R; Delogu G; Fadda G
    Infect Immun; 2006 Feb; 74(2):1352-9. PubMed ID: 16428784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs.
    Kim J; Cho YJ; Do E; Choi J; Hu G; Cadieux B; Chun J; Lee Y; Kronstad JW; Jung WH
    Fungal Genet Biol; 2012 Nov; 49(11):955-66. PubMed ID: 22975303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.
    Chang M; Sionov E; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378705
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole.
    Posteraro B; Sanguinetti M; Sanglard D; La Sorda M; Boccia S; Romano L; Morace G; Fadda G
    Mol Microbiol; 2003 Jan; 47(2):357-71. PubMed ID: 12519188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
    Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans.
    Bastos RW; Carneiro HCS; Oliveira LVN; Rocha KM; Freitas GJC; Costa MC; Magalhães TFF; Carvalho VSD; Rocha CE; Ferreira GF; Paixão TA; Moyrand F; Janbon G; Santos DA
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109169
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
    Basso LR; Gast CE; Bruzual I; Wong B
    J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
    Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
    Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.